| Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ... Science translational medicine 11 (501), eaav7816, 2019 | 184 | 2019 |
| Sensitizing the tumor microenvironment to immune checkpoint therapy RM Zemek, WL Chin, AK Nowak, MJ Millward, RA Lake, WJ Lesterhuis Frontiers in immunology 11, 223, 2020 | 61 | 2020 |
| Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ... Frontiers in Immunology 11, 584423, 2020 | 53 | 2020 |
| Cross-presentation of cutaneous melanoma antigen by migratory XCR1+CD103− and XCR1+CD103+ dendritic cells B Wylie, E Seppanen, K Xiao, R Zemek, D Zanker, S Prato, B Foley, ... Oncoimmunology 4 (8), e1019198, 2015 | 37 | 2015 |
| Bilateral murine tumor models for characterizing the response to immune checkpoint blockade RM Zemek, VS Fear, C Forbes, E de Jong, TH Casey, L Boon, ... Nature Protocols 15 (5), 1628-1648, 2020 | 24 | 2020 |
| Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice RM Zemek, WL Chin, VS Fear, B Wylie, TH Casey, C Forbes, CM Tilsed, ... Nature Communications 13 (1), 1-16, 2022 | 18 | 2022 |
| Retinoic acid induces an IFN-driven inflammatory tumour microenvironment, sensitizing to immune checkpoint therapy CM Tilsed, TH Casey, E de Jong, A Bosco, RM Zemek, J Salmons, G Wan, ... Frontiers in Oncology 12, 849793, 2022 | 7 | 2022 |
| CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy CM Tilsed, N Principe, J Kidman, WL Chin, MLO Morales, RM Zemek, ... Cell Reports 41 (13), 2022 | 6 | 2022 |
| PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective MLO Morales, CA Rinaldi, E de Jong, SM Lansley, JPA Gummer, B Olasz, ... Iscience 25 (1), 2022 | 6 | 2022 |
| A mouse model of incompletely resected soft tissue sarcoma for testing (Neo) adjuvant therapies FX Rwandamuriye, BJ Weston, TG Johns, WJ Lesterhuis, RM Zemek MyJoVE Corporation, 2020 | 6 | 2020 |
| Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment. Sci Transl Med RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ... | 5 | 2019 |
| Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment. Sci. Transl. Med. 11, eaav7816 RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ... | 5 | 2019 |
| Functional genomics in cancer immunotherapy: computational approaches for biomarker and drug discovery WL Chin, RM Zemek, WJ Lesterhuis, T Lassmann Molecular Systems Design & Engineering 4 (4), 689-700, 2019 | 5 | 2019 |
| A surgically optimized intraoperative poly (I: C)-releasing hydrogel prevents cancer recurrence FX Rwandamuriye, CW Evans, B Wylie, M Norret, B Vitali, D Ho, ... Cell Reports Medicine 4 (7), 2023 | 3 | 2023 |
| Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia S Kumari, RM Zemek, U Palendira, LM Ebert Immunology and Cell Biology 101 (9), 783-788, 2023 | 1 | 2023 |
| Method for immunotherapy drug treatment WJ Lesterhuis, R Lake, R Zemek, A Bosco, E De Jong US Patent App. 16/979,962, 2021 | 1 | 2021 |
| Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes J Kidman, RM Zemek, JW Sidhom, D Correa, N Principe, F Sheikh, ... OncoImmunology 13 (1), 2345859, 2024 | | 2024 |
| Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors FX Rwandamuriye, B Vitali, J Schreurs, T Wang, E Barrick, KS Iyer, ... STAR protocols 5 (2), 102948, 2024 | | 2024 |
| Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy WL Chin, RM Zemek, CM Tilsed, ARR Forrest, VS Fear, C Forbes, L Boon, ... Scientific Data 11 (1), 1-9, 2024 | | 2024 |
| Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner CM Tilsed, MLO Morales, RM Zemek, BA Gordon, MJ Piggott, AK Nowak, ... BMC cancer 24 (1), 203, 2024 | | 2024 |
